Corrigendum to "D-578, an orally active triple monoamine reuptake inhibitor, displays antidepressant and anti-PTSD like effects in rats" [Eur. J. Pharmacol. 862 (2019) 172632-172640]
Eur J Pharmacol
.
2022 Sep 15:931:175232.
doi: 10.1016/j.ejphar.2022.175232.
Epub 2022 Aug 26.
Authors
Aloke K Dutta
1
,
Soumava Santra
2
,
Arman Harutyunyan
3
,
Banibrata Das
2
,
Michael J Lisieski
3
,
Liping Xu
2
,
Tamara Antonio
4
,
Maarten E A Reith
4
,
Shane A Perrine
3
Affiliations
1
Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA. Electronic address: adutta@wayne.edu.
2
Wayne State University, Department of Pharmaceutical Sciences, Detroit, MI, 48202, USA.
3
Department of Psychiatry and Behavioral Neurosciences, School of Medicine, Wayne State University, USA.
4
New York University, Department of Psychiatry, New York, NY, 10016, USA.
PMID:
36038378
PMCID:
PMC9815471
DOI:
10.1016/j.ejphar.2022.175232
No abstract available
Publication types
Published Erratum
Grants and funding
R01 MH084888/MH/NIMH NIH HHS/United States